{"id":"W4389259069","doi":"10.1182/blood-2023-178822","title":"Oral Decitabine/Cedazuridine Is a Tolerable and Effective Ambulatory Regimen for Patients with Advanced Myeloproliferative Neoplasms","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Silence Therapeutics; Swedish Orphan Biovitrum; Astellas Pharma; Karyopharm Therapeutics; Galecto; Sierra Oncology; Incyte; CTI Biopharma; Gilead Sciences; MorphoSys; Celgene; GlaxoSmithKline; Constellation Pharmaceuticals; Bristol-Myers Squibb","keywords":"Medicine; Decitabine; Internal medicine; Ruxolitinib; Myelofibrosis; Oncology; Bone marrow; Gastroenterology; Febrile neutropenia; Neutropenia; Chemotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121657,0.00007520954,0.0002033079,0.0002234914,0.0001653088,0.0001464074,0.0001140047,0.0001172706,0.001361932],"category_scores_gemma":[0.0003530801,0.00004003337,0.0001054137,0.0003085142,0.00009092665,0.0001588054,0.0001368426,0.0001839548,0.000271704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001763906,"about_ca_system_score_gemma":0.0002295851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002290269,"about_ca_topic_score_gemma":0.0008316553,"domain_scores_codex":[0.9999117,0.0000186074,0.00001483466,0.00001617267,0.0000250801,0.00001376422],"domain_scores_gemma":[0.9997856,0.00002546397,0.0001116611,0.000009697505,0.00001265501,0.00005496138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003960279,0.0006608644,0.7447318,0.0005753252,0.0001186977,0.003034072,0.0001110911,0.0002542725,0.0159983,0.0001542497,0.00582838,0.2245728],"study_design_scores_gemma":[0.000339476,0.004875218,0.9515635,0.0001227138,0.0001257591,0.01178502,0.0001220844,0.0005622628,0.003222874,0.00008617047,0.02718475,0.00001023018],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896392,0.005712222,0.0003294719,0.0001738757,0.00001856464,0.0001213577,0.0008094591,0.00002831866,0.003167656],"genre_scores_gemma":[0.9965133,0.001489484,0.0004564683,0.0001218254,0.00003662874,0.00006641488,0.0008988659,0.000002789701,0.0004143126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001361932,"threshold_uncertainty_score":0.004556119,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007458680412565143,"score_gpt":0.2499339059953076,"score_spread":0.2424752255827425,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}